Catalyst Wire Dossier Catalyst Wire Dossier

MenC-TT

Meningococcal C conjugate vaccine with tetanus toxoid carrier protein · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MenC-TT, covering 2016-09-16 to 2016-09-16. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT and Hib-MenC-TT or Meningitec™ in Healthy Toddlers [Phase 2]

See pricing